Text Size:AAA

FAS / CD95 / APO-1 / TNFRSF6 抗體, 兔單抗

產品資料評論實驗方法
表達宿主: Human Cells  
  • Slide 1
10217-H08H-50
10217-H08H-100
50 µg 
100 µg 
Add to Cart
表達宿主: Human Cells  
  • Slide 1
10217-H02H-50
10217-H02H-100
50 µg 
100 µg 
Add to Cart
表達宿主: Human Cells  
  • Slide 1
50027-M08H-50
50027-M08H-100
50 µg 
100 µg 
Add to Cart
表達宿主: Human Cells  
  • Slide 1
80043-R08H-50
80043-R08H-100
50 µg 
100 µg 
Add to Cart
表達宿主: Human Cells  
  • Slide 1
80043-R02H-50
80043-R02H-100
50 µg 
100 µg 
Add to Cart
表達宿主: Human Cells  
  • Slide 1
90273-C02H-50
90273-C02H-100
50 µg 
100 µg 
Add to Cart
表達宿主: Human Cells  
  • Slide 1
90273-CCCH-50
90273-CCCH-100
50 µg 
100 µg 
Add to Cart

CD95/APO-1/TNFRSF6 AntibodyRelated Products

Related Products

Featured Reagent Products

CD95/APO-1/TNFRSF6 antibody 研究背景

CD95 (APO-1/Fas) is an important inducer of the extrinsic apoptosis signaling pathway and therapy induced apoptosis of many tumor cells has been linked to the activity of CD95. is a prototype death receptor characterized by the presence of an 80 amino acid death domain in its cytoplasmic tail. This domain is essential for the recruitment of a number of signaling components upon activation by either agonistic anti-CD95 antibodies or cognate CD95 ligand that initiate apoptosis. The complex of proteins that forms upon triggering of CD95 is called the death-inducting signaling complex (DISC). The DISC consists of an adaptor protein and initiator caspases and is essential for induction of apoptosis. CD95 is also crucial for the negative selection of B cells within the germinal center (GC). Impairment of CD95-mediated apoptosis results in defective affinity maturation and the persistence of autoreactive B-cell clones. Changes in the expression of CD95 and/or its ligand CD95L are frequently found in human cancer. The downregulation or mutation of CD95 has been proposed as a mechanism by which cancer cells avoid destruction by the immune system through reduced apoptosis sensitivity. Thus, CD95 has therefore been viewed as a tumor suppressor. CD95 has been reported to be involved in the activation of NF-kappaB, MAPK3/ERK1, MAPK8/JNK, and the alternate pathways for CTL-mediated cytotoxicity. Accordingly, this protein is implicated in the pathogenesis of various malignancies and diseases of the immune system. The CD95/CD95L system was implicated in the etiology of inflammatory bowel disease (IBD) based, primarily, on the finding that CD95 is highly expressed in the intestinal epithelial cells and that epithelial apoptosis is increased in IBD.

小鼠 CD95/APO-1/TNFRSF6 antibody 參考資料
  • Mschen M, et al. (2002) The origin of CD95-gene mutations in B-cell lymphoma. Trends Immunol. 23(2): 75-80.
  • Peter ME, et al. (2003) The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 10(1): 26-35.
  • Peter ME, et al. (2005) Does CD95 have tumor promoting activities Biochim Biophys Acta. 1755(1): 25-36.
  • Chen L, et al. (2010) Cell death in the colonic epithelium during inflammatory bowel diseases: CD95/Fas and beyond. Inflamm Bowel Dis. 16(6): 1071-6.
  • 請注意:所有產品都是“僅用於科研,而不能用於診斷或治療用途”